Alveus Therapeutics

Philadelphia, PA · Founded 2023 · Privately Held (backing)

Developer of biological and small-molecule treatments designed for metabolic disease management. Alveus Therapeutics is based in Philadelphia, PA and was founded in 2023. It was valued at $275 million at its early-stage round in Feb 2026, the last priced event on record. It has raised $202 million across 1 recorded round; the latest was a $56.9 million later-stage round in Dec 2025.

PMV mark · valuation
$275.2M
Oct 2026
Priced at
its early-stage round
Feb 2026
Total raised
$202.0M
Last round
Later Stage VC
Dec 2025
How much has Alveus Therapeutics raised?
$202.0Macross 1 recorded rounds · Dec 2025 – Dec 2025

Most recently, Alveus Therapeutics raised $56.9M in its Later Stage VC (Dec 2025).

Free account
More of Alveus Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Alveus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alveus Therapeutics round by round

1 rounds
Dec 2025Later Stage VC$56.9MSEC filing▮
17 investors participated

How much has Alveus Therapeutics raised?

Alveus Therapeutics has raised $202 million in total; 1 of its rounds is on record. The largest on record was a $56.9 million later-stage round in Dec 2025.

Alveus Therapeutics investors

13 investors are on record for Alveus Therapeutics, including Novo Holdings, Kurma Partners, Andera Partners and Omega Funds. The later-stage round in Dec 2025 drew 17 investors.

For fundraisers
Raising for a company like Alveus Therapeutics?

13 investors have backed Alveus Therapeutics.

See all 13 investors →

Frequently asked about Alveus Therapeutics

How much has Alveus Therapeutics raised?
Alveus Therapeutics has raised $202.0M in total across 1 recorded funding rounds.
When was Alveus Therapeutics's last funding round?
Alveus Therapeutics's most recent recorded round was Later Stage VC in Dec 2025, raising $56.9M.
Alveus Therapeutics Funding Rounds & Investors — $202.0M Raised | Premier Alternatives